Drugs / Subcuvia
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02556437 | Jun 2016 → May 2018 | multifocal motor neuropathy | Johannes Jakobsen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Subcuvia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02556437 ↗ |
| Modality | Protein / enzyme biologic | “Human immunoglobulin 16% for subcutaneous injection” NCT02556437 ↗ |
| Route | Subcutaneous | “Human immunoglobulin 16% for subcutaneous injection” NCT02556437 ↗ |